Does your sanitiser guarantee your protection against SARS-CoV2?

BIODX LAUNCHES FIRST AND ONLY ‘EUROPEAN ACCREDITED’ DISINFECTANT WITH CONVINCING EU SARS-CoV2 TEST RESULTS

In what can only be called a ground breaking result, not only for Biodx but also South Africa in the ongoing fight against Coronavirus, Biodx has received the official confirmation from TNO (The Netherlands Organisation for applied scientific research) that our active ingredient b bioactive™, has a 99.987% reduction against the SARS-CoV2 virus for surface disinfection and hand sanitisers.

Why is SARS-CoV2 testing necessary?

Why test for efficacy against the SARS-CoV-2 (the virus that causes COVID-19) when no one else seems to bother? According to Burt Rodrigues, CEO of Biodx, “Although, in science one is allowed to speculate on the activity of a product on a given pathogen based on its recorded activity against another pathogen; however, ultimately one is obliged to have direct scientific proof of this claimed activity.“Most claims that are being made are based on work done on other viruses,” explains leading Virologist Dr Alex Alexandre from the CSIR, “however it is necessary that if a product claims to be active against SARS-CoV-2 it must be tested specifically against this virus. Because it works on one virus it doesn’t necessarily mean that it will work against other viruses no matter how related they may be.”

Why test with TNO?

Founded in 1932, this organisation is rated as one of the top such facilities in the world employing some of the finest minds in science today. “We chose TNO for this testing work in 2014 when looking for a European applied science research partner. They are also ranked in the top 20 scientific institutions in the world and their analytical reports are accepted worldwide,” explains Rodrigues. 

Legally sanctioned

According to experts this is now the only South African manufactured product offering a guarantee of safe, fully effective usage against this virus. When people buy products that advertise efficacy against SARS-CoV-2, they trust the words on the label, but rarely look further to see who has certified the product. Most importantly what it actually contains is often a questionable substance, banned due to high human toxicity. And herein lies the problem. Government legislation is in place here, perhaps without the same capacity as the EU, but do formulators / manufacturers comply, guaranteeing a kill rate against SARS-CoV2 meeting the internal requirements of their claims? This, now more than ever is vital if we want to really contain this pandemic. 

Safer for people, equipment and planet

Biodx b bioactive™ guarantees a unique element of safety, being non-corrosive for both people and equipment, is completely alcohol-free and safer for the planet. 

Who would benefit from this guarantee of performance providing residual efficacy?

Responsible formulators/producers of quality commercial, industrial and consumer cleaning products, sanitisers and disinfectants and most importantly, end users (cleaning companies, medical, commercial, industrial, consumers etc.) “If responsible companies want to stay within their fiduciary duties which hold companies liable to eliminate this risk then b bioactive™is the product of choice,” adds Rodrigues. 

Every surface can kill

Just last week ATMs came under the spotlight when Cooperative Governance and Traditional Affairs Minister Nkosazana Dlamini-Zuma brought in new regulations calling for the provision of sanitisers at every ATM, as they could be a source of mass infections. “If banks conform to this demand it should be through using wet wipes that contain b bioactive™ to guarantee usage safety,” urges Rodrigues. 

For more information on the test results and criteria/protocol for the EU NEN-EN 14476:2013 +A2:2019 method please contact Dr Mark Kelly, Chief Scientist at Biodx.

For more info on b bioactive™ and where to purchase it, please contact Biodx at https://biodx.co/bbioactive/This email address is being protected from spambots. You need JavaScript enabled to view it. or +27 (0)11 608 0732